Skip to main content
. 2020 Nov 21;26(3):494–506. doi: 10.1007/s10147-020-01829-0

Fig. 2.

Fig. 2

a Overall response rate b progression-free survival and c overall survival among patients stratified according to the primary site. BOR best overall response, CR complete response, NR not reached, ORR objective response rate, OS overall survival, PD progressive disease, PFS progression-free survival, PR partial response, SD stable disease. *Primary tumor types excluded from Checkmate 141 study